The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, and growing importance of technologies such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 230,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Mobile health in medical: sleep apnea treatment devices. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s Technology Foresights, which uses over 165,000 patents to analyze innovation intensity for the medical devices industry, there are 35+ innovation areas that will shape the future of the industry.
Sleep apnea treatment devices is a key innovation area in mobile health
Sleep apnea treatment devices refer to a variety of devices or systems that are designed to monitor and/or treat individuals with sleep apnea, a common sleep disorder characterized by pauses in breathing or shallow breaths during sleep.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 200 companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of sleep apnea treatment devices.
Key players in sleep apnea treatment devices – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to sleep apnea treatment devices
Source: GlobalData Patent Analytics
Omron and Nyxoah are two of the leading patent filers in Sleep apnea treatment devices. Some other key patent filers in the field include Coloplast, Omron Tateisi Electronics, and Johnson & Johnson.
In terms of application diversity, Encite leads the pack, while Somne and GyroGear stood in the second and third positions, respectively. By means of geographic reach, Omron held the top position, followed by Omron Tateisi Electronics and IntraPace.
The outlook for sleep apnea treatment devices appears positive due to the advancements in wearable sensor technologies, personalized continuous positive airway pressure machines, and telemedicine, which are expected to provide real-time monitoring, and comprehensive data in healthcare. With ongoing developments in home sleep testing, these devices will reduce the need for in-person visits, making treatment more convenient and accessible.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
